Page 2 of 2.
In total there are 14 English news articles.
The common marmoset is highly susceptible to certain bacterial infections. This may be related to a relative lack of diversity in genes controlling the immune response. A recent study has confirmed this lack of diversity, but suggests that compensating mechanisms may be operating at the genetic level.
Monkey YM received a kidney transplant 25 years ago and is still in good health, despite receiving no immunosuppressive treatment for the last 24 years.
The success rate of human kidney transplants has increased dramatically during those 25 years, in part because of lessons learnt from research in animals.
Suppression of ongoing disease in a nonhuman primate model of multiple sclerosis by a human-anti-human IL-12p40 antibody
We have recently reported a new method for testing the effectivity of new immunotherapies for multiple sclerosis using magnetic resonance imaging techniques in marmosets, thereby quantifying the activity of lesions within the brain white matter.
‘t Hart BA, Brok HP, Remarque E, Benson J, Treacy G, Amor S, Hintzen RQ, Laman JD, Bauer J, Blezer EL: Suppression of ongoing disease in a nonhuman primate model of multiple sclerosis by a human-anti-human IL-12p40 antibody.
J Immunol. 2005 Oct 1;175(7):4761-8. (PubMed)
The first malaria vaccine invented by a Dutch research team at the BPRC, Rijswijk will begin a clinical trial conducted by a team at RUNMC, Nijmegen on November 29st 2005.
Malaria is one of the most devastating global health problems. It kills as many as 2 million children each year in Africa alone. There is currently no vaccine commercially available that can prevent malaria. A vaccine for malaria is badly needed and a critical tool to control this deadly disease.